TAG:
lab test
In Florida, UnitedHealth Delays BeaconLBS Claims Decisions
By Robert Michel | From the Volume XXII No. 1 – January 5, 2015 Issue
LAST WEEK, ONE PART OF THE Beacon Laboratory Benefit Solutions pilot program in Florida was postponed. A UnitedHealthcare spokesperson provided additional information about this decision. “We have lifted the January 1 claims impact de…
Health Diagnostic Lab Pushes Back on Federal Fraud Probe, Cigna Suit
By Joseph Burns | From the Volume XXII No. 1 – January 5, 2015 Issue
HEALTH DIAGNOSTIC LABORATORY of Richmond, Virginia, is mounting its own offensive against the dual blows it suffered recently: a federal fraud investigation and a lawsuit by Cigna, a health insurer in Bloomfield, Connecticut. In September, The Wall Street Journal reported that federal …
Why ‘Bad Actors’ Continue to Operate in Lab Industry
By Robert Michel | From the Volume XXII No. 1 – January 5, 2015 Issue
OVER THE PAST TWO DECADES, pathologists and lab managers have regularly watched certain new lab companies burst on the scene and generate startling growth in revenue and profits by offering proprietary tests–often unsupported by published clinical studies that …
January 5, 2015 Intelligence: Late Breaking News
By Robert Michel | From the Volume XXII No. 1 – January 5, 2015 Issue
In Vermont, a multi-year effort to create a statewide single-payer health insurance program has failed. On December 17, Governor Peter Shumlin announced that the state would not go forward with its plans to create a health program called Green Mountain Care. “The bottom line is that… it b…
Is PAML to Be Sold? ‘No Comment!’ Say Execs
By Robert Michel | From the Volume XXI No. 17 – December 15, 2014 Issue
CEO SUMMARY: It is one of the 10 largest lab companies in the United States. Thus, if Pathology Associates Medical Laboratories in Spokane, Washington, were to be sold, it would trigger a major shift in the competitive market for lab testing service…
Top 10 2014 Biggest News Stories
By Robert Michel | From the Volume XXI No. 17 – December 15, 2014 Issue
Story no.1 SGR Fix by Congress Spawns PAMA;Â Lab Industry Wary of Law’s Impact ON APRIL 1, PRESIDENT BARACK OBAMA signed into law the Protecting Access to Medicare Act of 2014 (PAMA). As written, it has the potential to be the most impactful federal legislation on the clinical lab industry s…
Preparing the Next Generation of Lab Leaders
By R. Lewis Dark | From the Volume XXI No. 17 – December 15, 2014 Issue
ACROSS THE LAB TESTING INDUSTRY, individual labs are caught in a serious conundrum. On one hand, the ongoing transformation of healthcare and the erosion of lab test revenues are putting the financial squeeze on a large number of clinical labs and pathology groups. On the other hand, at the very mom…
December 15, 2014 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXI No. 17 – December 15, 2014 Issue
In certain respects, the noted physician and healthcare strategist Eric Topol, M.D., of Scripps Healthcare in La Jolla, California, can be considered a gadfly to pathology and the laboratory medicine profession. In his latest pronouncements on patient-centered healthcare, he warned c…
More Genetic Counseling Leads to Fewer Lab Tests
By Joseph Burns | From the Volume XXI No. 17 – December 15, 2014 Issue
CEO SUMMARY: Cigna was the first national health insurer to require independent board-certified genetic counseling before approving coverage for certain genetic tests. Since launching this program in September 2013, the insurer has seen a 450% increase in genetic counseling for Cigna …
PAMA, LDTs and Theranos Top 2014 Biggest News
By Robert Michel | From the Volume XXI No. 17 – December 15, 2014 Issue
CEO SUMMARY: Not in recent memory has a single calendar year brought such a cascade of news stories that have the potential to affect nearly every clinical lab and pathology group in the United States. Blame it on the lack of money to fund healthcare and how it is motivating government an…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized